Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The NHS Commissioning Board (operating under the name of NHS England)
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
Contact person: Philip Grieve
E-mail: philip.grieve@nhs.net
NUTS: UK
Internet address(es)
Main address: https://www.england.nhs.uk/
Address of the buyer profile: https://www.england.nhs.uk/
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin
Reference number: CM/PHS/17/5550
II.1.2) Main CPV code
33651520
II.1.3) Type of contract
Supplies
II.1.4) Short description
National Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
II.1.6) Information about lots
This contract is divided into lots:
Yes
II.1.7) Total value of the procurement
Value excluding VAT:
1 200 000 000.00
GBP
II.2) Description
Lot No: 1
II.2.1) Title
Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Please refer to Document 04d Schedule 8 in the ITO for the list of purchasing points
II.2.4) Description of the procurement
5% Intravenous Immunoglobulin (5% IVIg)
II.2.5) Award criteria
Quality criterion: Security of Supply
/ Weighting: 30%
Quality criterion: usability
/ Weighting: 10%
Price
/ Weighting:
60%
II.2.11) Information about options
Options:
Yes
Description of options:
option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Please refer to Document 04d Schedule 8 in the ITO for the list of purchasing points
II.2.4) Description of the procurement
10% Intravenous Immunoglobulin (10% IVIg)
II.2.5) Award criteria
Quality criterion: Security of Supply
/ Weighting: 30%
Quality criterion: Usability
/ Weighting: 10%
Price
/ Weighting:
60%
II.2.11) Information about options
Options:
Yes
Description of options:
option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
Lot 3: Subcutaneous Immunoglobulin (SCIg)
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Please refer to Document 04d Schedule 8 in the ITO for the list of purchasing points
II.2.4) Description of the procurement
Subcutaneous Immunoglobulin (SCIg)
II.2.5) Award criteria
Quality criterion: Usability
/ Weighting: 10%
Quality criterion: Security of Supply
/ Weighting: 30%
Price
/ Weighting:
60%
II.2.11) Information about options
Options:
Yes
Description of options:
option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 4
II.2.1) Title
Lot 4: Facilitated Subcutaneous Immunoglobulin (fSCIg)
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Please refer to Document 04d Schedule 8 in the ITO for the list of purchasing points
II.2.4) Description of the procurement
Facilitated Subcutaneous Immunoglobulin (fSCIg)
II.2.5) Award criteria
Quality criterion: Security of Supply
/ Weighting: 30%
Quality criterion: Usability
/ Weighting: 10%
Price
/ Weighting:
60%
II.2.11) Information about options
Options:
Yes
Description of options:
option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 5
II.2.1) Title
Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Please refer to Document 04d Schedule 8 in the ITO for the list of purchasing points
II.2.4) Description of the procurement
5: 5% Intravenous Immunoglobulin (5% IVIg)
II.2.5) Award criteria
Quality criterion: Security of Supply
/ Weighting: 30%
Quality criterion: Usability
/ Weighting: 10%
Price
/ Weighting:
60%
II.2.11) Information about options
Options:
Yes
Description of options:
option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 6
II.2.1) Title
Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Please refer to Document 04d Schedule 8 in the ITO for the list of purchasing points
II.2.4) Description of the procurement
10% Intravenous Immunoglobulin (10% IVIg)
II.2.5) Award criteria
Quality criterion: Security of Supply
/ Weighting: 30%
Quality criterion: Usability
/ Weighting: 10%
Price
/ Weighting:
60%
II.2.11) Information about options
Options:
Yes
Description of options:
option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 7
II.2.1) Title
Lot 7: Subcutaneous Immunoglobulin (SCIg)
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Please refer to Document 04d Schedule 8 in the ITO for the list of purchasing points
II.2.4) Description of the procurement
Subcutaneous Immunoglobulin (SCIg)
II.2.5) Award criteria
Quality criterion: Security of Supply
/ Weighting: 30%
Quality criterion: Usability
/ Weighting: 10%
Price
/ Weighting:
60%
II.2.11) Information about options
Options:
Yes
Description of options:
option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 8
II.2.1) Title
Lot 8: Facilitated Subcutaneous Immunoglobulin (fSCIg)
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
Facilitated Subcutaneous Immunoglobulin (fSCIg)
II.2.5) Award criteria
Quality criterion: Security of Supply
/ Weighting: 30%
Quality criterion: Usability
/ Weighting: 10%
Price
/ Weighting:
60%
II.2.11) Information about options
Options:
Yes
Description of options:
option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 9
II.2.1) Title
Lot 9: Anti-D Immunoglobulin (Anti-D)
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Please refer to Document 04d Schedule 8 in the ITO for the list of purchasing points
II.2.4) Description of the procurement
Anti-D Immunoglobulin (Anti-D)
II.2.5) Award criteria
Quality criterion: Security of Supply
/ Weighting: 30%
Quality criterion: Usability
/ Weighting: 10%
Price
/ Weighting:
60%
II.2.11) Information about options
Options:
Yes
Description of options:
option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2021/S 000-001317
Section V: Award of contract
Lot No: Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Octapharma Limited
Manchester
M2 1AB
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Shire Pharmaceuticals Ltd
London
W2 6BD
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Biotest UK Limited
Longbridge
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Grifols UK Ltd.
Cambridge
CB4 0WZ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Bio Products Laboratory Ltd
Elstree
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Octapharma Limited
Manchester
M2 1AB
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Shire Pharmaceuticals Ltd
London
W2 6BD
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Biotest UK Limited
Longbridge
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
LFB
London
N6 9BR
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Grifols UK Ltd.
Cambridge
CB4 0WZ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Bio Products Laboratory Ltd
Elstree
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
CSL Behring UK Ltd
Haywards Heath
RH16 1AH
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 3: Subcutaneous Immunoglobulin (SCIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Octapharma Limited
Manchester
M2 1AB
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 3: Subcutaneous Immunoglobulin (SCIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Shire Pharmaceuticals Ltd
London
W2 6BD
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 3: Subcutaneous Immunoglobulin (SCIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Bio Products Laboratory Ltd
Elstree
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 3: Subcutaneous Immunoglobulin (SCIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
CSL Behring UK Ltd
Haywards Heath
RH16 1AH
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 4: Facilitated Subcutaneous Immunoglobulin (fSCIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Shire Pharmaceuticals Ltd
London
W2 6BD
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Octapharma Limited
Manchester
M2 1AB
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Shire Pharmaceuticals Ltd
London
W2 6BD
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Biotest UK Limited
Longbridge
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
LFB
London
N6 9BR
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Grifols UK Ltd.
Cambridge
CB4 0WZ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Bio Products Laboratory Ltd
Elstree
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
CSL Behring UK Ltd
Haywards Heath
RH16 1AH
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Octapharma Limited
Manchester
M2 1AB
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Shire Pharmaceuticals Ltd
London
W2 6BD
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Biotest UK Limited
Longbridge
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Grifols UK Ltd.
Cambridge
CB4 0WZ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Bio Products Laboratory Ltd
Elstree
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 7: Subcutaneous Immunoglobulin (SCIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Octapharma Limited
Manchester
M2 1AB
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 7: Subcutaneous Immunoglobulin (SCIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Shire Pharmaceuticals Ltd
London
W2 6BD
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 7: Subcutaneous Immunoglobulin (SCIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Bio Products Laboratory Ltd
Elstree
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 7: Subcutaneous Immunoglobulin (SCIg)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
CSL Behring UK Ltd
Haywards Heath
RH16 1AH
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 9: Anti-D Immunoglobulin (Anti-D)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Bio Products Laboratory Ltd
Elstree
B31 2UQ
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 9: Anti-D Immunoglobulin (Anti-D)
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
CSL Behring UK Ltd
Haywards Heath
RH16 1AH
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: Lot 8: Facilitated Subcutaneous Immunoglobulin (fSCIg) Suppliers Awarded (1) OJEU Criteria (3) Tab
Title: Human Normal Immunoglobulin and Anti-D Immunoglobulin
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/06/2021
V.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Shire Pharmaceuticals Ltd
London
W2 6BD
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
The High Court
Strand
London
WC2A 2LL
UK
E-mail: generaloffice@administrativecourtoffice.justice.gov.uk
Internet address(es)
URL: https://www.gov.uk/courts-tribunals
VI.5) Date of dispatch of this notice
22/07/2021